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Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections
of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. The organism is however,
commonly encountered as a commensal in healthy individuals where it is a component of the normal
microflora. The key determinant in the type of relationship that Candida has with its host is how it interacts
with the epithelial surface it colonises. A delicate balance clearly exists between the potentially damaging
effects of Candida virulence factors and the nature of the immune response elicited by the host. Frequently, it
is changes in host factors that lead to Candida seemingly changing from a commensal to pathogenic existence.
However, given the often reported heterogeneity in morphological and biochemical factors that exist between
Candida species and indeed strains of C. albicans, it may also be the fact that colonising strains differ in the
way they exploit resources to allow persistence at mucosal surfaces and as a consequence this too may affect
the way Candida interacts with epithelial cells. The aim of this review is to provide an overview of some of the
possible interactions that may occur between C. albicans and host epithelial surfaces that may in turn dictate
whether Candida removal, its commensal persistence or infection follows.
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T
he Candida genus consists of approximately 200
species of ‘yeast-like’ fungi and collectively repre-
sents a highly heterogenic group (1). Taxonomi-
cally, the Candida genus is in the class Deuteromycetes,
and a feature of Candida species is their ability to grow
polymorphically, either in the form of budding yeasts
(blastoconidia) or filaments (true hyphae and pseudohy-
phae). The reason for this heterogeneity in the Candida
genus largely stems from the fact that historically,
designation of organisms to the genus was based on the
absence of a known sexual reproduction stage. In many
instances, Candida species have since been shown to
reproduce sexually, but have retained their taxonomic
status within Candida. As a consequence, Candida species
can differ greatly in terms of their biochemistry, mor-
phology, genetic composition and, importantly, their
ability to instigate human infection.
In the case of human infections caused by Candida, the
terms candidosis (sing.) or candidiasis are used, and can-
didoses (pl.) can broadly be categorised as being systemic
or superficial. Systemic infections generally develop in
severely immunocompromised individuals and whilst
these infections are relatively rare, they are associated
with high mortality. In contrast, superficial infections on
moist mucosal surfaces, such as those of the mouth and
vagina are more prevalent, but have less damaging effects
to the host.
Approximately, 20 Candida species have, at some point,
been associated with causing candidosis in humans. The
species most frequently isolated from humans and the
causative agent of the majority of infections is, however,
Candida albicans and it is this species that is the focus of
this review.
Candida albicans is an opportunistic pathogen and
generally exists as a harmless commensal of humans,
primarily on moist mucosal surfaces, particularly of the
gut, vagina, and oral cavity. Depending on the population
studied, commensal carriage in the oral cavity can range
between 40 and 60% (2). In the case of the vagina, Candida
colonisation rates again vary with studied groups, with
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carriage rates of 41 and 21% reportedly occurring in type 1
and type 2 diabetic patients, respectively (3). Women who
are pregnant also reportedly have a high incidence of
vaginal carriage (4), and vaginal candidosis is one of the
most common superficial infections in reproductive-age
women (5).
Given that C. albicans colonises host surfaces at such a
high prevalence, infections are unsurprisingly often en-
dogenous (6), occurring when there is an ecological shift
in the microbiological community, frequently due to
debilitation in the host’s immune system. Receipt of a
broad-spectrum antibiotic, a high frequency intake of
carbohydrates, hormonal imbalances, and poor nutrition
may also be contributory factors. Interestingly, in the case
of oral candidosis four clinically distinct forms of infection
are recognised (Fig. 1) and these could reflect different
forms of interaction between the colonising Candida and
host epithelium. The four clinically distinct primary forms
of oral candidosis are acute erythematous candidosis,
pseudomembranous candidosis, chronic erythematous
candidosis, and chronic hyperplastic candidosis. Clinical
symptoms of acute erythematous candidosis include red-
ness and soreness of the oral mucosa with the tongue most
often affected. Pseudomembranous candidosis is most
common in infants and immunocompromised people and
typically manifests as creamy white plaques or patches on
oral tissues that can usually be scraped off. Chronic
erythematous candidosis presents as localised erythema
in regions of ill-fitting or inadequately cleaned dentures.
Chronic hyperplastic candidosis is seen as firmly adhered
white patches on the oral mucosa.
To successfully persist within the host environment,
either as a commensal or as a pathogen, Candida first has
to adhere and then colonise host surfaces. These surfaces
may take the form of the biomaterials of medical devices,
for example, the acrylic of a denture, or the host’s mucosal
surfaces.
Adherence of Candida to mucosal surfaces
The process of initial adherence of Candida to human
epithelial surfaces is complex and multifactorial. Cell
surfaces (both Candida and epithelial cells) are generally
negatively charged, and establishing successful adherence
is, in part, dependent on the sum of non-specific factors
contributing to the total free energy of interaction. These
include attractive Lifshitzvan der Waals forces, hydro-
phobic interaction, and Brownian movement forces, as well
as the repulsive effects of the electrical double layer of
cells. Such interactions form the basis of the extended
DerjaguinLandauVerweyOverbeek (DLVO) theory (7).
Once the ‘long-distance’ repulsive forces have been
overcome, adherence of Candida is then mediated by
specific molecules, referred to as adhesins, on the fungal
cell surface and these interact with specific ligands on the
host cell surface (Table 1). Adhesins on the cell surface of
C. albicans can interact with serum proteins, components
of the extracellular matrix (ECM), immobilised ligands
such as cadherins or integrins, or indirectly via other
microorganisms (28). An important serum component
that C. albicans can bind to is Factor H (FH; 29) which is
a key regulator of the alternative pathway (AP) of
complement and incorporation of FH on the surface of
C. albicans prevents AP activation (30). Laminin, fibro-
nectin, collagen, entactin, vitronectin, and tenascin are all
ECM proteins that C. albicans can interact with (31).
Members of the agglutinin-like sequence (ALS) gene
family of C. albicans encode for large cell-wall glycopro-
teins, some of which are implicated in the adhesion of the
organism to host surfaces (25, 32). The ALS gene family
comprises of eight members (Als1Als7, and Als9) and
all have a similar three-domain structure and are asso-
ciated with the b-1,6-glucan of the cell wall of C. albicans
(a)
(b)
(c)
(d)
Fig. 1. Clinically distinct forms of primary oral candidosis.
(a) Acute erythematous candidosis; (b) pseudomembranous
candidosis; (c) chronic erythematous candidosis; (d) chronic
hyperplastic candidosis.
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(23). In the case of C. albicans, Als3 appears to play a key
role in adhesion to oral epithelial cells, and it is also
related to the extent of subsequent epithelial damage and
induction of epithelial cytokines (33).
Hyphal wall protein 1 (Hwp1; encoded for by the
HWP1 gene) is another protein involved in C. albicans
adhesion to epithelial cells and this protein is perhaps the
most widely studied adhesin of C. albicans (34). Gluta-
mine residues in the N-terminal domain of Hwp1 can be
cross-linked to unidentified host proteins by host trans-
glutaminase activity and this leads to covalent attachment
of the yeast to host epithelial cells. This interaction has
been shown to be important for C. albicans colonisation
within the oral cavity (35).
The b-1,3-glucan motif of the cell wall of C. albicans
and indeed other pathogenic fungi (36), has been shown
to interact with Dectin-1 on the surfaces of host cells,
primarily on phagocytotic cells including dendritic cells
within the oral epithelium. As such, several studies have
shown that Dectin-1 belongs to the armoury of pathogen
recognition molecules participating in host defence
against fungal pathogens, including Candida species and
Aspergillus species (37, 38). Dectin-1 can synergise with
toll-like receptor (TLR) 2 and TLR4 signals and promote
Th1 and Th17 responses to activate antifungal host
defences (3941). Further detail concerning Dectin-1
and fungal interactions in respect to immune responses
is provided later in this review.
Recently, the gene encoding the C. albicans protein,
EAP1 (Enhanced Adherence to Polystyrene) was identi-
fied. This gene was originally investigated because of its
ability to encode for a protein mediating adhesion to
polystyrene of a Saccharomyces cerevisiae flocculin-
deficient strain. EAP1 encodes for a glycosylphosphatidy-
linositol-anchored, glucan-cross-linked cell-wall protein
that has since been shown to facilitate adhesion of C.
albicans to epithelial cells as well as polystyrene (28).
Once adherence to mucosal surfaces has been estab-
lished, colonisation and growth of C. albicans is required
to maintain the presence of the organism at the host site.
The extent of this colonisation is key to determining
whether eradication, commensal carriage, or infection
subsequently follows. The ability of C. albicans to
generate a biofilm on host surfaces, including mucosa,
is also an important attribute toward such persistence.
Biofilm formation by C. albicans on mucosal
surfaces
Biofilms are defined as microbial communities that are
often attached to solid substrata with the biofilm cells
themselves embedded within extracellular polymeric sub-
stances (EPS) that they have generated. C. albicans is
particularly adept at forming biofilms on the acrylic of
dentures and also on mucosal surfaces (Fig. 2). In the
case of pseudomembranous candidosis, the pseudomem-
branes that develop on the oral mucosa have been shown
to be typical biofilms and linked to the recalcitrant nature
of the condition (42). Once the biofilm has formed, the
EPS encasing the cells may contribute to persistence of
the organism by several possible mechanisms. First, the
EPS may serve to sequester antimicrobial substances
that are present in oral secretions or within administered
agents thereby limiting diffusion into the biofilm and
access to cells. Similarly, restricted access of phagocytotic
cells to C. albicans within the biofilm will also occur.
It has also been suggested that altered cell phenotypes,
potentially with reduced growth rates of biofilm cells
provides an additional means of protection against host
defence molecules. An important regulator of C. albicans
biofilm formation is the transcription factor Bcr1, which
is a positive regulator of several candidal adhesin
genes including HYR1, HWP1, CHT2, ECE1, RBT5,
ALS1, and ALS3 (43, 44). The importance of Bcr1 in C.
albicans biofilm formation within in a mouse model of
oral infection has recently been demonstrated (45).
Damage induced by C. albicans to epithelial
cell surfaces
To propagate at mucosal sites, nutrients may be acquired
from the surrounding milieu or through degradation of
host tissue structures. The latter may also allow penetra-
tion of C. albicans hyphae into deeper layers of the
Table 1. Examples of Candida albicans adhesins and associated host cell ligands
Candida adhesin Host cell receptor References
Integrin analog (INT) iC3b, Arginineglycineaspartic acid (RGD) (811)
Fibronectin adhesin (FN) Fibronectin and vitronectin receptors (1214)
Fucoside-binding adhesin Glycoside (glycoprotein or glycolipid) receptor (1518)
GlcNAc-binding protein N-Acetylglucosamine (1517)
Fimbrial adhesin bGalNAc(14b-Gal) (19)
Hyphal wall protein 1 (HWP1) A substrate of epithelial cell-associated transglutaminases facilitating
cross-linking with epithelial cells
(20, 21)
Agglutinin-like sequence (ALS) family Multiple receptors including E-cadherin, N-cadherin and host cell ferritin (2225)
Enhanced adherence to polystyrene (EAP1) Host cell targets not yet identified (26, 27)
Candida and epithelium
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epithelium (Fig. 2), which would further enhance persis-
tence of the organism on oral surfaces, which, in the oral
cavity has a high cellular turnover partly serving as a
defence mechanism to remove colonised cells.
As previously mentioned, C. albicans is an opportunis-
tic pathogen and as such it can be argued that it does not
possess potent virulence factors, certainly when compared
with other strict pathogens. However, C. albicans can
generate a number of hydrolytic enzymes with broad
substrate activity that can damage host cell structures.
Perhaps, the most extensively studied extracellular hydro-
lytic enzymes of C. albicans are the secreted aspartyl
proteinases (SAPs).
The SAP family of C. albicans is currently known to
comprise 10 genes encoding for proteinases with masses of
3550 kDa. SAPs 13 and SAPs 46 are thought to
represent two subfamilies (46). The SAP genes are
differentially regulated depending on the surrounding
environment and are thought to be involved in the
pathogenesis of C. albicans. SAP16 gene expression
appears to be related to adherence, tissue damage, and
changes in the immune response (4649). SAPs 46 are
expressed by C. albicans during hyphal invasion of a
reconstituted human oral epithelium (RHE; 50) and oral
infection (51). SAPs 46 are also linked with hyphal
formation, invasion of the epithelium (52), and apoptosis
of epithelial cells (53). SAPs 2 and 6 are also potent
inducers of IL-1b, TNF-a, and IL-6 production by
monocytes (54). The SAP gene products are suggested to
contribute to various virulence processes in vitro including
adherence to and invasion of the epithelial cells (55, 56).
However, all the SAPs have distinct pH optima and the
extent of their functional activity at the generally neutral
pH of oral mucosa remains to be ascertained.
E-cadherin is a protein associated with epithelial cell
junctions that serves to maintain a functional barrier to
invasion. In vitro breakdown of E-cadherin, produced by
oral epithelial cells by SAP5, has been demonstrated and
this could represent a mechanism by which C. albicans
mediates invasion of oral mucosa (56).
Fig. 2. Candida albicans biofilm formation on oral mucosal surfaces.
Arrows indicate green fluorescing C. albicans (stained with a labelled peptide nucleic acid probe) infecting a reconstituted oral
epithelium generated commercially from transformed human keratinocytes of the cell line TR146 (from a squamous cell
carcinoma of the buccal mucosa; SkinEthic Laboratories, Nice, France); nuclei of epithelial keratinocytes are shown as blue
(Hoescht staining).
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In addition to SAPs, C. albicans also has two other
gene families, namely the lipases (LIP) and phospholi-
pases (PL) that produce extracellular hydrolytic enzymes
that could play roles in candidal adhesion, nutrient
acquisition and invasion of epithelial surfaces (57, 58).
The LIP gene family of C. albicans comprises at least 10
genes (LIP110) (59), whilst seven phospholipase genes
of C. albicans have been identified (PLA, PLB1, PLB2,
PLC1, PLC2, PLC3, and PLD1) (60). Constitutive
expression of the LIP genes and PLB has been demon-
strated in C. albicans biofilms generated on an RHE (61).
Epithelial cell responses to C. albicans
Epithelial cells of host mucosal surfaces represent the first
line of defence against Candida infection. As key cells in
the innate immunity of the host, epithelial cells express
pattern recognition receptors (PRRs), which recognise
C. albicans. PRRs interact with pathogen-associated
molecular patterns (PAMPs) on microbial cells and
examples of these in C. albicans include cell-wall compo-
nents and nucleic acids. PRRs are divided into three major
groups, TLRs, C-type lectin receptors (CLRs) and nod-
like receptors (NLRs). Within these receptor groups, only
certain TLRs and CLRs on epithelial surfaces recognise
Candida. In addition to PRRs, other cell-surface proteins,
such as E-cadherin and Epidermal Growth Factor Recep-
tor (EGFR), can also recognise Candida and as discussed
previously, these are unsurprisingly implicated in Candida
adherence and endocytosis (62, 63).
Cell-surface recognition of Candida produces a cascade
cell signaling reaction, which leads to gene expression in
epithelial cells for a number of growth factors, chemo-
kines/cytokines, antimicrobial peptides, and cell matrix
proteins (64, 65). Epithelial responses to Candida may not
however, result in a strong host immune response and
inflammation. Indeed, certain candidal factors as well as
proteins produced by epithelial cells may actually result in
anti-inflammatory effects and subsequent immune toler-
ance (66). The precise features that determine whether
epithelial cells induce inflammation or are acquiescent
toward C. albicans remain unclear. In the following sec-
tion, we will summarise the general mechanisms involved
in epithelial cell responses to Candida, including cell-
surface receptor binding, cell signaling triggering, and the
factors produced by the epithelial cells.
TLRs are a family of PRRs whose involvement in host
innate immune responses to various pathogens has been
well studied. Up to 13 TLRs have been identified in both
humans and mice. Expression of TLR1, 2, 4, 5, and 6
has been demonstrated in human mucosal epithelial cells
(6468), and their expression in response to C. albicans
infecting both oral and vaginal epithelial cell lines has
been shown to be similar (69). The exact composition of
the PRRs used by epithelial cells in response to infections
with C. albicans is, however, unknown (69). TLR2 and
TLR5 are both expressed at high levels by oral cells and
are frequently associated with epithelial repair, growth,
and survival (70, 71).
Candida stimulates human epithelial cells to express
(granulocyte-macrophage colony-stimulating factor) GM-
CSF, which is a highly potent cytokine that stimulates
dendritic cell maturation to mediate mucosal inflamma-
tion. Interestingly, TLR4 is not involved in GM-CSF
stimulation and it has also been shown that candidal
viability is also required in GM-CSF induction (72).
Aside from TLRs, perhaps the most important PRRs
for Candida recognition are CLRs. CLRs comprise a
family of six cell-surface proteins. Dectin-1 and Dectin-2
belong to this family, and are confirmed receptors for
Candida recognition (7375). Whilst the role of Dectin-1
and 2 in host immunity against Candida infection has been
extensively studied in animal models and human macro-
phages/dendritic cells, only Dectin-1 expression in human
oral gingival epithelial cells has been reported, and its
expression is at best weak (76). Therefore, the exact role of
Dectin-1 expression in oral mucosal immunity remains
unclear.
Epithelial cells can also recognise the morphology of
the colonising Candida. C. albicans yeast and hyphae both
trigger Nuclear Factor Kappa b (NFkb) activation in
epithelial cells, but NFkb activation alone does not lead to
cytokine release. Only C. albicans hyphae appear to be
able to also induce mitogen-activated protein kinases
(MAPK) phosphorylation, which combined with NFkb
activation results in production of IL-6 and GM-CSF by
epithelial cells (34, 77, 78). Despite the identification of
such downstream inflammatory signaling cascades, the
oral epithelial receptor(s) that induce(s) cytokine re-
sponses to Candida have yet to be identified. The receptors
described above might be involved in differential detection
of Candida hyphae, thus representing a possible mechan-
ism by which the host distinguishes between commensal
Candida yeast carriage (resulting in immune tolerance)
and invasive Candida hyphal infection (resulting in
inflammatory immune responses).
Many downstream mechanisms have been identified as
influencing immune tolerance and activation following
Candida colonisation. Examples include involvement of
the resident macrophages in the mucosa that produce
anti-inflammatory cytokines to regulate host immune
responses (66). Nevertheless, details of the mechanisms of
Candida recognition and host tolerance by mucosal
epithelial cells still need to be clarified.
Candida also induces in vitro upregulation of various
antimicrobial peptides such as b-defensins and LL-37
(79, 80), which are known to have candidacidal activity
and could play significant roles in combating infections
and invasion, as well as initiating other immune responses
(81, 82).
Candida and epithelium
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Summary
It is clear that a delicate balance exists between C.
albicans and host epithelial surfaces. The type of response
elicited by the epithelial surface to colonising Candida is
extremely important given that such surfaces are the first
line of defence of the host to infection. The nature of
mucosal responses is affected by many variables including
host factors such as immune dysfunction, underlying
disease, other forms of host debilitation, and the compo-
sition of the existing microflora community. In addition,
there are factors associated with the strain of C. albicans
involved that are also important in determining responses
of the epithelium. These include the level of expression of
putative virulence factors including cell-surface adhesins,
extracellular hydrolytic enzymes, and the type of mor-
phology exhibited by the colonising C. albicans. Given
the heterogeneity associated with such factors in both the
Candida genus and amongst strains of C. albicans, it
could readily be postulated that those strains able to
adapt to the conditions at the mucosal surface without
inducing host responses represent those most likely to
successfully persist as commensals. Strains that rely on
virulence factors to persist are those that lead either to
pathology or become eradicated through the activity of
host defences.
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